Beta 2-adrenergic treatment of neonatal hypoxic disorders
Lundell, K.H.; Hedner, T.; Iversen, K.
European Journal of Respiratory Diseases 62(5): 360-362
1981
ISSN/ISBN: 0106-4339 PMID: 6124441 Document Number: 173699
The effects of terbutaline, a .beta.2-receptor stimulating drug, in 9 O2 or transcutaneous PO2. Except for a moderate tachycardia, no side effects were noted. .beta.2-receptor stimulating drugs may have beneficial effects in the treatment of neonatal respiratory disorders accompanied by hypoxia. One possible explanation is a decrease in the pulmonary vasoconstriction induced by hypoxia.